Amrutanjan Health Care Ratios

Amrutanjan Health Care Ltd Ratios

The Amrutanjan Health Care Ltd Ratios page provides a complete fundamental analysis of Amrutanjan Health Care Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Amrutanjan Health Care Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Amrutanjan Health Care Ltd (NSE: AMRUTANJAN, BSE: 590006) is currently trading at ₹515.55, with a market capitalization of ₹15.01B. As a major player in the Health technology sector and Pharmaceuticals: other industry, Amrutanjan Health Care Ltd remains a key stock for fundamental analysis using Amrutanjan Health Care Ltd Ratios.

Amrutanjan Health Care Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Amrutanjan Health Care Ltd P/E ratio currently stands at 36.67, making it one of the most tracked metrics in Amrutanjan Health Care Ltd Ratios.

Historically, the Amrutanjan Health Care Ltd P/E ratio has shown strong fluctuations:

• 2024: 36.67
• 2023: 39.92
• 2022: 42.18
• 2021: 34.54
• 2020: 27.15

The decline in Amrutanjan Health Care Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Amrutanjan Health Care Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 5.71.

Historical P/B trend:

• 2024: 5.71
• 2023: 6.20
• 2022: 5.77
• 2021: 8.74

Amrutanjan Health Care Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The Amrutanjan Health Care Ltd P/S ratio currently stands at 4.13, an important part of Amrutanjan Health Care Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 4.13
• 2023: 4.26
• 2022: 4.43
• 2021: 5.72

A stable or declining Amrutanjan Health Care Ltd P/S ratio indicates cautious market sentiment.

Amrutanjan Health Care Ltd Price to Cash Flow Ratio (P/CF)

The Amrutanjan Health Care Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 27.85.

Historical Amrutanjan Health Care Ltd Price to Cash Flow Ratio:

• 2024: 27.85
• 2023: 42.71
• 2022: 53.49
• 2021: 35.80
• 2020: 17.42

The declining Amrutanjan Health Care Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Amrutanjan Health Care Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Amrutanjan Health Care Ltd EV currently stands at ₹16.67B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 16.67B
• 2023: 15.86B
• 2022: 16.06B
• 2021: 22.26B

Amrutanjan Health Care Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Amrutanjan Health Care Ltd EV/EBITDA ratio is currently 27.28, a key metric in Amrutanjan Health Care Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 27.28
• 2023: 28.96
• 2022: 33.13
• 2021: 26.31

Stable Amrutanjan Health Care Ltd EV/EBITDA indicates balanced valuation.

Amrutanjan Health Care Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Amrutanjan Health Care Ltd D/E ratio is currently 0.01, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.01
• 2023: 0.01
• 2022: 0
• 2021: 0

Amrutanjan Health Care Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Amrutanjan Health Care Ltd ROE currently stands at 16.53%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 16.53
• 2023: 15.53
• 2022: 14.33
• 2021: 27.96

Amrutanjan Health Care Ltd maintains stable profitability levels.

Amrutanjan Health Care Ltd Ratios Analysis Summary

The Amrutanjan Health Care Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Amrutanjan Health Care Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Amrutanjan Health Care Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.